Luisa Escobar-Hoyos envisions a world where a pancreatic cancer diagnosis is no longer a death sentence. “Every time I tell people I work on pancreatic cancer, people are like, ‘That’s a really bad ...

When news breaks, you need to understand what actually matters — and what to do about it. At Vox, our mission to help you make sense of the world has never been more vital. But we can’t do it on our ...

Exclusive: People from deprived and minority ethnic backgrounds have better access to device than for previous technologies The rollout of a “life-changing” artificial pancreas on the NHS for people ...

A new drug for pancreatic cancer is showing promise in early testing. Daraxonrasib is a daily pill designed to block cancer signals linked to the RAS gene. It has now finished an early-stage clinical ...

Kerry Breen is a news editor at CBSNews.com. A graduate of New York University's Arthur L. Carter School of Journalism, she previously worked at NBC News' TODAY Digital. She covers current events, ...

An experimental drug that could be a breakthrough in the treatment of one of the deadliest known cancers is driving demand at clinics while awaiting full government approval. Daraxonrasib, a drug that ...

RAS oncoproteins, once considered undruggable, are now being successfully targeted by new drugs like daraxonrasib, showing dramatically improved survival in pancreatic cancer patients. Personalized ...

The drug's benefits significantly outweigh its adverse effects, researchers say Survival time is roughly doubled with daraxonrasib vs standard chemotherapy Drug targets a mutation found in 90% of ...

Get unlimited access to ad-free articles and exclusive content. An AI model developed at the Mayo Clinic in Rochester, Minnesota, detected abnormalities on patients’ CT scans up to three years before ...

Ben Sasse says he’s still alive thanks to "providence, prayer and a miracle drug." The 54-year-old former U.S. senator from Nebraska was told he had four months to live at most last December when he ...

New clinical trial data show KRAS-blocking drugs may significantly improve survival for the disease. “I think this is truly an earth-shattering moment in pancreatic cancer.” Daraxonrasib, an ...